Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy
Erin M. Corsini, Wai Chin Foo, K. G. Mitchell, Nicolas Zhou, Dipen M. Maru, Jaffer A. Ajani, Wayne L. Hofstetter, Arlene M. Correa, Mara B. Antonoff, Steven H. Lin, Reza J. Mehran, Ravi Rajaram, David C. Rice, Jack A. Roth, Boris Sepesi, Stephen G. Swisher, Ara A. Vaporciyan, Garrett L. Walsh
Topics & Concepts
MedicineEsophageal cancerAdenocarcinomaProto-oncogene tyrosine-protein kinase SrcInternal medicineCarcinomaOncologyHistologyNeoadjuvant therapyBiopsyGastroenterologyPathologyCancerBreast cancerReceptorEsophageal Cancer Research and TreatmentGastrointestinal Tumor Research and TreatmentGastric Cancer Management and Outcomes